je.st
news
Novartis says study shows secukinumab works in spinal inflammation condition
2015-06-10 09:36:28| Biotech - Topix.net
ZURICH: Novartis AG said one-year results of its drug secukinumab show it is effective in treating patients with ankylosing spondylitis , a debilitating joint condition of the spine.
Tags: works
study
shows
condition
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||